<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>创鉴汇 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-31T20:32:13+08:00</updated>
  <subtitle>鉴别创新，鉴赏创业。生物医健，全球视野。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>再生细胞疗法IND申请获FDA批准，新锐公司完成新一轮融资，全新疗法能否成功？</title>
    <updated>2020-12-31T17:39:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/gew4Nt8Aq35nFCGTRa5khA</id>
    <link href="https://mp.weixin.qq.com/s/gew4Nt8Aq35nFCGTRa5khA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新型CAR细胞，癌症早筛，帕金森病疗法…2020年这十个生物医学领域进步瞩目！</title>
    <updated>2020-12-31T17:39:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/ZUa3aQipf8mEL4naUW-mGg</id>
    <link href="https://mp.weixin.qq.com/s/ZUa3aQipf8mEL4naUW-mGg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专注个体化癌症疫苗研发，新锐公司完成最新一轮融资</title>
    <updated>2020-12-30T17:29:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/H9IGtEXSyAufMax1LzFqKw</id>
    <link href="https://mp.weixin.qq.com/s/H9IGtEXSyAufMax1LzFqKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《自然》：早期投资助力微生物组疗法发展</title>
    <updated>2020-12-29T21:52:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/PA5OjRd7hHpmsuAE0-Eltw</id>
    <link href="https://mp.weixin.qq.com/s/PA5OjRd7hHpmsuAE0-Eltw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MedTech盘点 | 飞利浦28亿美元收购远程医疗技术公司，沛嘉医疗与High Life就TMVR产品达成合作协议</title>
    <updated>2020-12-29T21:52:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/pmXnTvE_-Owjru5SgMHblQ</id>
    <link href="https://mp.weixin.qq.com/s/pmXnTvE_-Owjru5SgMHblQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>加科思药业登陆港交所，艺妙神州、思派健康、卡尤迪等获资本青睐|大健康行业投融资周报</title>
    <updated>2020-12-28T09:38:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/5zsqHI5dBz5TWxBpDkyc0Q</id>
    <link href="https://mp.weixin.qq.com/s/5zsqHI5dBz5TWxBpDkyc0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年生物医药行业会有哪些发展趋势？</title>
    <updated>2020-12-25T21:35:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/eACuPFyqppN7NnMyOuCRnQ</id>
    <link href="https://mp.weixin.qq.com/s/eACuPFyqppN7NnMyOuCRnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>眼科新锐B轮融资4690万美元，创新疗法能否为患者带来光明？</title>
    <updated>2020-12-24T18:17:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/29Se_E6Bs46nT8S4u66Ocw</id>
    <link href="https://mp.weixin.qq.com/s/29Se_E6Bs46nT8S4u66Ocw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新锐公司完成A轮1.09亿美元融资，开发创新蛋白降解疗法</title>
    <updated>2020-12-23T21:53:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/7vTU_QKKelpFBgzgcZEwIA</id>
    <link href="https://mp.weixin.qq.com/s/7vTU_QKKelpFBgzgcZEwIA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年生物医药M&amp;A市场中，哪些公司值得关注？</title>
    <updated>2020-12-22T22:26:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/qli8liNupQgXp-XPw9xZxA</id>
    <link href="https://mp.weixin.qq.com/s/qli8liNupQgXp-XPw9xZxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>AbCellera登陆纳斯达克；鹍远基因、柏惠维康、微脉等受知名资本青睐 | 大健康行业投融资周报</title>
    <updated>2020-12-21T10:47:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/gkxmf2o09IVFj2iLTyBQiw</id>
    <link href="https://mp.weixin.qq.com/s/gkxmf2o09IVFj2iLTyBQiw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抑制病毒能治疗慢性疾病？新锐公司拟IPO，登陆纳斯达克</title>
    <updated>2020-12-18T19:00:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/IZDqopHk1XAbdEm0hYE-zQ</id>
    <link href="https://mp.weixin.qq.com/s/IZDqopHk1XAbdEm0hYE-zQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>